M Isabel Fiel

Author PubWeight™ 50.77‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology 2004 2.54
2 Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol 2009 2.42
3 A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006 2.32
4 Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. J Hepatol 2008 2.22
5 Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis 2008 1.78
6 Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007 1.77
7 Medullary thymic epithelial cell depletion leads to autoimmune hepatitis. J Clin Invest 2013 1.57
8 Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. J Hepatol 2013 1.52
9 Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology 2009 1.48
10 Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 2011 1.46
11 De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci 2006 1.45
12 Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology 2005 1.44
13 Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters--a pilot study. Radiology 2012 1.31
14 Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression. J Hepatol 2005 1.21
15 Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol 2009 1.01
16 Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients. J Acquir Immune Defic Syndr 2004 0.95
17 Clinical characterization of patients developing histologically-proven fibrosing cholestatic hepatitis C post-liver transplantation. Hepatol Res 2011 0.94
18 The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV. Virchows Arch 2010 0.93
19 Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl 2006 0.90
20 Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl 2009 0.90
21 DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility. J Magn Reson Imaging 2013 0.88
22 Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clin Infect Dis 2012 0.88
23 Hepatocellular carcinoma associated with an atypical presentation of Wilson's disease. Semin Liver Dis 2007 0.87
24 Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature. Am J Surg Pathol 2011 0.87
25 Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patients. Ann Surg Oncol 2013 0.87
26 Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use. Semin Liver Dis 2009 0.86
27 Rapid regression of atherosclerosis with MTP inhibitor treatment. Atherosclerosis 2013 0.85
28 Invasive colloid carcinoma arising from intraductal papillary neoplasm in a 50-year-old woman with primary sclerosing cholangitis. Semin Liver Dis 2004 0.84
29 Liver failure in an antimitochondrial antibody-positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis 2005 0.84
30 Recurrent hepatic sarcoidosis post-liver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl 2005 0.84
31 Obliterative portal venopathy: a clinical and histopathological review. Dig Dis Sci 2013 0.84
32 Recurrent hepatitis C after retransplantation: factors affecting graft and patient outcome. Liver Transpl 2005 0.82
33 Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal. Ann Surg Oncol 2014 0.82
34 Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma. Liver Transpl 2008 0.81
35 Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics. Arch Pathol Lab Med 2014 0.81
36 Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol 2012 0.81
37 Diagnosis of 6 mercaptopurine hepatotoxicity post liver transplantation utilizing metabolite assays. Am J Transplant 2004 0.81
38 Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin. Transplantation 2007 0.79
39 Liver pathology in obesity. Semin Liver Dis 2004 0.78
40 Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size. J Immunother 2016 0.78
41 Multiple inflammatory and serum amyloid A positive telangiectatic hepatic adenomas with glycogenated nuclei arising in a background of nonalcoholic steatohepatitis. Semin Liver Dis 2008 0.77
42 Acute cellular rejection resulting in sinusoidal obstruction syndrome and ascites postliver transplantation. Transplantation 2011 0.77
43 Maternal allergy acts synergistically with cigarette smoke exposure during pregnancy to induce hepatic fibrosis in adult male offspring. J Immunotoxicol 2011 0.77
44 Advancing the diagnosis and treatment of hepatocellular carcinoma. Liver Transpl 2005 0.77
45 To B(iopsy) or not to B(iopsy) …. Clin Gastroenterol Hepatol 2010 0.75
46 Lamivudine resistance leading to de novo hepatitis B infection in recipients of hepatitis B core antibody positive liver allografts. Hepatol Res 2013 0.75
47 Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation. Liver Transpl 2007 0.75
48 Hepatic mass in a 73-year-old man. Gastroenterology 2012 0.75
49 Mucosal addressin cell adhesion molecule (MAdCAM-1) expression is upregulated in the cirrhotic liver and immunolocalises to the peribiliary plexus and lymphoid aggregates. Dig Dis Sci 2013 0.75
50 Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series. Liver Transpl 2009 0.75